Emerging Company ProfileArgonaut: Focused on productivity

Traditional drug discovery consists of three stages - screening, design and synthesis. Of the three, compound synthesis is the most time-consuming and labor-intensive. Medicinal chemists synthesize new chemicals in a slow, repetitive and ultimately expensive process that has proven to be a bottleneck in drug development. In contrast, drug companies can screen compounds rapidly with automated, high throughput screens and receptor binding assays.

Argonaut Technologies is developing enabling hardware for pharmaceutical companies to use in synthesizing new compounds. In addition, it is creating a line of software, reagents and consumable products for automating medicinal chemistry.